Backed by an excellent compliance history and track record, Albany Molecular Research Inc.'s (AMRI) worldwide manufacturing facilities are equipped for Phase I through commercial API manufacturing.
AMRI also provides an added advantage as you move your compound from discovery to commercial manufacturing. Our global sites in the United States, Europe and Asia are positioned to provide tailored solutions and to enable the efficient, cost-effective transfer of pre-clinical and commercial drug products – from small-scale to large-scale production. We can provide raw materials, starting materials and cGMP manufacturing of API. We have an experienced staff using substantial global capacity.
In choosing AMRI as a manufacturing partner, customers can expect to receive a combination of qualities that are unmatched in the industry, including: